4.8 Article

Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 13, Issue 35, Pages 41464-41472

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.1c12235

Keywords

copper sulfide nanoparticles; glucose oxidase; Fenton reaction; cancer therapy; starvation therapy

Funding

  1. China Postdoctoral Science Foundation [2019M653139, 2019M653979]
  2. Guangdong Province Higher Vocational College and Schools Pearl River Scholar Funded Scheme
  3. Canada Research Chairs Program, New Frontiers in Research Fund-Exploration [NFRFE-2018-01005]
  4. Project of Scientific and Technological Foundation of Shenzhen, China [GJHZ20180928161212140]
  5. Cape Breton University RISE program
  6. NSERC Discovery Grants Program
  7. Canada's Telus Ride for Dad (RFD)
  8. The Prostate Cancer Fight Foundation (PCFF)
  9. Post-doctoral Foundation Project of Shenzhen Polytechnic [6019330001K, 6019330006K, 6019330007K]

Ask authors/readers for more resources

A simple formulation of glucose-oxidase-coated CuS nanoparticles has shown high effectiveness in melanoma treatment, utilizing a synergistic combination of glucose starvation, photothermal therapy, and advanced chemodynamic therapy enabled by near-infrared irradiation coupled with Fenton-like reactions enhanced by endogenous chloride.
Multimodal nanotherapeutic cancer treatments are widely studied but are often limited by their costly and complex syntheses that are not easily scaled up. Herein, a simple formulation of glucose-oxidasecoated CuS nanoparticles was demonstrated to be highly effective for melanoma treatment, acting through a synergistic combination of glucose starvation, photothermal therapy, and synergistic advanced chemodynamic therapy enabled by near-infrared irradiation coupled with Fenton-like reactions that were enhanced by endogenous chloride.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available